Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model
Noha H. Sayed, Nevine Fathy, Mona A. Kortam, et al.
Neurotherapeutics (2019) Vol. 17, Iss. 1, pp. 252-268
Open Access | Times Cited: 104

Showing 51-75 of 104 citing articles:

The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin as a Candidate Treatment for Disorders of Consciousness: A Deep Learning and Retrospective Clinical Analysis
Daniel Toker, Jeffrey N. Chiang, Paul Vespa, et al.
Neurocritical Care (2025)
Open Access
Donepezil-Based Rational Design of N-Substituted Quinazolinthioacetamide Candidates as Potential Acetylcholine Esterase Inhibitors for the Treatment of Alzheimer’s Disease: In vitro and In vivo Studies
Ahmed A. Al‐Karmalawy, Ahmed F. Mohamed, Heba Nasr Shalaby, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Antioxidant and Anti-Inflammatory Defenses in Huntington’s Disease: Roles of NRF2 and PGC-1α, and Therapeutic Strategies
Francesco D’Egidio, Elvira Qosja, Fabrizio Ammannito, et al.
Life (2025) Vol. 15, Iss. 4, pp. 577-577
Open Access
The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders
Junchen Si, Kai Yu, Jiheng Hao, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice
B Ali, Ahmed R. Abu‐Raghif, Hayder Ridha‐Salman, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 3
Closed Access
Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders
Abhishek Gupta, Sumedha Gupta, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease
Lígia Fão, A. Cristina Rego
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 8, pp. 650-673
Closed Access | Times Cited: 26
Can dipeptidyl peptidase-4 inhibitors treat cognitive disorders?
Qi Cheng, Jinluo Cheng, Dennis Cordato, et al.
Pharmacology & Therapeutics (2020) Vol. 212, pp. 107559-107559
Closed Access | Times Cited: 24
Role of PI3K/Akt axis in mitigating hippocampal ischemia-reperfusion injury via CB1 receptor stimulation by paracetamol and FAAH inhibitor in rat
Sherif S. Abdel Mageed, Ramy M. Ammar, Noha N. Nassar, et al.
Neuropharmacology (2021) Vol. 207, pp. 108935-108935
Closed Access | Times Cited: 22
Inhibition of Brain GTP Cyclohydrolase I Attenuates 3-Nitropropionic Acid-Induced Striatal Toxicity: Involvement of Mas Receptor/PI3k/Akt/CREB/ BDNF Axis
Aya M. Mustafa, Mostafa A. Rabie, Hala F. Zaki, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Movement Disorder and Neurotoxicity Induced by Chronic Exposure to Microcystin-LR in Mice
Minghao Yan, Haibo Jin, Chun Pan, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 9, pp. 5516-5531
Closed Access | Times Cited: 16
Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade
Yara T. Mohamed, Abeer Salama, Mostafa A. Rabie, et al.
International Immunopharmacology (2022) Vol. 114, pp. 109571-109571
Closed Access | Times Cited: 16
Omarigliptin/galangin combination mitigates lipopolysaccharide-induced neuroinflammation in rats: Involvement of glucagon-like peptide-1, toll-like receptor-4, apoptosis and Akt/GSK-3β signaling
Ahmed M. Kabel, Hany H. Arab, Aliaa Atef, et al.
Life Sciences (2022) Vol. 295, pp. 120396-120396
Closed Access | Times Cited: 15
Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: Cross talk between PPAR-γ and PI3K/Akt/GSK-3β pathway
Nora O. Abdel Rasheed, Weam W. Ibrahim
Life Sciences (2022) Vol. 297, pp. 120480-120480
Closed Access | Times Cited: 15
The Role of Adipokines in the Pathologies of the Central Nervous System
Korbinian Huber, Emilia Szerenos, Dawid Lewandowski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14684-14684
Open Access | Times Cited: 8
Mechanistic insights on the role of Nrf-2 signalling in Huntington’s disease
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh
Neurological Sciences (2024)
Closed Access | Times Cited: 3
Mutant Huntingtin Impairs Pancreatic β-cells by Recruiting IRS-2 and Disturbing the PI3K/AKT/FoxO1 Signaling Pathway in Huntington’s Disease
Li Li, Yun Sun, Yinong Zhang, et al.
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 12, pp. 2646-2658
Closed Access | Times Cited: 19
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's disease
Maanvi, Shilpa Kumari, Rahul Deshmukh
European Journal of Pharmacology (2022) Vol. 939, pp. 175426-175426
Closed Access | Times Cited: 14
CREB-mediated generation and neuronal growth regulates the behavioral improvement of geniposide in diabetes-associated depression mouse model
Bo Sun, Xiayan Jia, Fei Yang, et al.
Neuroscience Research (2020) Vol. 165, pp. 38-44
Closed Access | Times Cited: 20
Terpene-augmented novasomal gels for the sustainment of rasagiline mesylate delivery; A new approach for treating Parkinson's disease induced by rotenone in rats
Hala N. ElShagea, Rana R. Makar, Alaa H. Salama, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105369-105369
Closed Access | Times Cited: 2
Mitochondria, Mitophagy, Mitoptosis, and Programmed Cell Death: Implications from Aging to Cancer
Kenneth Maiese
Current Neurovascular Research (2024) Vol. 21, Iss. 1, pp. 1-5
Closed Access | Times Cited: 2
Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntingtonʼs disease in rats: An electrophysiological study
Fereshteh Badini, Mohammad Ali Mirshekar, Samira Shahraki, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5939-5951
Closed Access | Times Cited: 2
Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting
Mona E Noureldeen, Nancy N. Shahin, Hebat Allah A. Amin, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
The role of neuron-like cell lines and primary neuron cell models in unraveling the complexity of neurodegenerative diseases: a comprehensive review
Kianoush Ghiasvand, Mehdi Amirfazli, Parvaneh Moghimi, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2

Scroll to top